EUVIMEDEUVIMED entdecken
Crossref

Horse Spleen Apoferritin‐Encapsulated Organoruthenium Complex Bearing Pyrazolyl–Pyridine Ligand for Cytotoxic and Antimicrobial Resistance Modulations

Arangasamy Mounica, Balasubramani Saveetha, Arumugam Madan Kumar, Mani Ganeshpandian iD

Chemistry – An Asian Journal · 2025

DOI: 10.1002/asia.202500781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2025. Verfasst von Arangasamy Mounica und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, 603203, India. Hauptthemen laut MEDLINE: Apoferritins, Ruthenium, Pyridines, Antineoplastic Agents. Die Arbeit nennt 57 Literaturangaben. Gefördert von: DST-FIST, Anusandhan National Research Foundation (ANRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Horse spleen apoferritin is a highly efficient nanocarrier for encapsulating and delivering metallodrugs, resulting in enhanced stability and therapeutic effectiveness. Herein, Horse spleen apoferritin nanocage( Aftn ) is used to encapsulate the model organoruthenium complex bearing a pyrazolyl–pyridine ligand ( Ru(bpy) ) via a pH‐induced disassembly/reassembly method to obtain Ru(bpy)‐loaded nanoformulation ( Ru–Aftn ). This nanoformulation exhibits sustained release of the loaded complex over a period of 6 days with minimal burst release. Ru–Aftn also displays prominent cytotoxicity with better selectivity than the non‐encapsulated Ru(bpy) complex against MCF‐7 breast cancer cells. AO/EB staining assay revealed that the non‐encapsulated complex induced late apoptosis before loading, whereas early apoptosis occurred after being loaded into Aftn. These results support that Aftn can act as a promising carrier for metallodrugs in modulating their molecular mechanism. Nevertheless, it fails to improve the antimicrobial activity of Ru(bpy) when tested against ancomycin‐resistant Enterococcus ( VRE ) strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoferritinsRutheniumPyridinesAntineoplastic AgentsCoordination ComplexesSpleenAnti-Bacterial AgentsPyrazolesAnimalsHumansHorsesApoptosisMCF-7 CellsLigandsMicrobial Sensitivity TestsDrug Screening Assays, AntitumorCell ProliferationMolecular StructureCell Survival

Stichwörter der Autor:innen

Antimicrobial activityCytotoxicityHorse spleen apoferritinMetallodrug deliveryRu–arene complex

Substanzen

ApoferritinsRutheniumPyridinesAntineoplastic AgentsCoordination ComplexesLigandsAnti-Bacterial AgentsPyrazolespyridine

Autor:innen und Institutionen

  • Department of Chemistry, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, 603203, India.
  • Cancer Biology Lab, Molecular and Nanomedicine Research unit, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.

ORCID-Profile: Mani Ganeshpandian

Förderung

  • DST-FIST
  • Anusandhan National Research Foundation (ANRF)

Zitieren

APA

Mounica, A., Saveetha, B., Madan Kumar, A., & Ganeshpandian, M. (2025). Horse Spleen Apoferritin‐Encapsulated Organoruthenium Complex Bearing Pyrazolyl–Pyridine Ligand for Cytotoxic and Antimicrobial Resistance Modulations. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202500781

Vancouver

Mounica A, Saveetha B, Madan Kumar A, Ganeshpandian M. Horse Spleen Apoferritin‐Encapsulated Organoruthenium Complex Bearing Pyrazolyl–Pyridine Ligand for Cytotoxic and Antimicrobial Resistance Modulations. Chemistry – An Asian Journal. 2025. doi:10.1002/asia.202500781

BibTeX
@article{Mounica2025,
  author = {Mounica, Arangasamy and Saveetha, Balasubramani and Madan Kumar, Arumugam and Ganeshpandian, Mani},
  title = {Horse Spleen Apoferritin‐Encapsulated Organoruthenium Complex Bearing Pyrazolyl–Pyridine Ligand for Cytotoxic and Antimicrobial Resistance Modulations},
  journal = {Chemistry – An Asian Journal},
  year = {2025},
  doi = {10.1002/asia.202500781}
}
Kostenlos starten →